1. Kaprin A.D., Starinskiy V.V., Shakhzadova A.O. (eds.) Malignant neoplasms in Russia in 2019 (incidence and mortality). Moscow: Hertsen Moscow Oncology Research Center — Branch of NMRRC of the Ministry of Health of Russia, 2020 (In Russ.)
2. Oleynik E.K., Shibaev M.I., Oleynik V.M. Immunological status of gastrointestinal tumour patientsin Karelia. Immunology. 2004; 25(2):100–3 (In Russ.).
3. Solovyeva I.G., Egorov D.N., Cherenkova M.M., Vardosanidze K.V., Chernykh E.R., Abraov V.V. HLA-DR expression in monocytesand treatment outcomes in gastric cancer. Medical Immunology. 2004; 6(6):523–8 (In Russ.).
4. Arii K., Tanimura H., Iwahashi M., Tsunoda T., Tani M., Noguchi K., et al. Neutrophil functions and cytokine production in patients with gastric cancer. Hepatogastroenterology. 2000;47(31):291–7.
5. Bennett M.W., O’Сonnell J., O’Sullivan G.C., Roche D., Brady C., Kelly J., et al. Expression of Fas ligand by human gastric adenocarcinomas: a potential mechanism of immune escape in stomach cancer. Gut. 1999;44(2):156–62. DOI: 10.1136/gut.44.2.156